Date published: 2025-10-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

ICMT Inhibitors

ICMT inhibitors belong to a class of chemical compounds specifically designed to target and modulate the activity of the ICMT enzyme, which stands for "Isoprenylcysteine carboxyl methyltransferase." ICMT is a vital enzyme involved in the post-translational modification of proteins by catalyzing the methylation of isoprenylated cysteine residues. This modification is crucial for the proper functioning of many signaling proteins, particularly those involved in cellular growth, proliferation, and membrane trafficking. Inhibitors designed to target ICMT are primarily employed in molecular and cellular biology research to investigate the functional properties and regulatory mechanisms associated with this enzyme. The development of ICMT inhibitors typically involves a combination of biochemical, biophysical, and structural approaches aimed at identifying or designing molecules that can selectively interact with ICMT and modulate its activity in the context of protein methylation. By inhibiting ICMT, these compounds can potentially disrupt the methylation of critical signaling proteins, affecting cellular processes dependent on proper protein modification.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(E,E)-Farnesyl Thiol

138077-74-4sc-497781
100 mg
$420.00
(0)

(E,E)-Farnesyl Thiol functions as an isoprenylcysteine carboxyl methyltransferase (ICMT) substrate, playing a crucial role in post-translational modifications. Its unique thiol group facilitates nucleophilic attacks, enabling efficient methylation of isoprenylated proteins. This compound exhibits distinct reactivity patterns, influencing protein localization and stability. The kinetics of its interactions suggest a rapid turnover, impacting cellular signaling pathways and protein interactions significantly.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$215.00
$622.00
5
(1)

Manumycin A is a farnesyltransferase inhibitor that might decrease ICMT expression by reducing the need for its enzymatic activity.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$28.00
$88.00
$332.00
12
(1)

Lovastatin inhibits HMG-CoA reductase, potentially decreasing isoprenoid biosynthesis and subsequent demand for ICMT activity.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$30.00
$87.00
$132.00
$434.00
13
(1)

Simvastatin, another HMG-CoA reductase inhibitor, may lead to lower levels of substrates for prenylation, indirectly affecting ICMT.

Pravastatin

81093-37-0sc-222188
50 mg
$400.00
1
(1)

Pravastatin is part of the statin class of chemicals and might decrease ICMT expression by limiting the supply of isoprenoids.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$252.00
$495.00
9
(1)

Atorvastatin is an HMG-CoA reductase inhibitor, which could theoretically reduce ICMT expression by decreasing prenylation substrates.

Rosuvastatin

287714-41-4sc-481834
10 mg
$142.00
8
(0)

As a statin, Rosuvastatin might indirectly downregulate ICMT by limiting the availability of isoprenoid intermediates.

Alendronate acid

66376-36-1sc-337520
5 g
$135.00
2
(0)

Alendronate inhibits farnesyl diphosphate synthase, potentially reducing prenylation and thus ICMT expression.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$90.00
$251.00
5
(0)

Zoledronic acid inhibits farnesyl diphosphate synthase which could lead to decreased demand for ICMT activity.

Risedronic acid

105462-24-6sc-203239
100 mg
$107.00
2
(1)

Risedronate inhibits farnesyl diphosphate synthase, potentially reducing the substrate availability for ICMT.